Exploring the link between Bipolarity and medical diseases: an investigation of risk factors and biological characteristics for better prevention and treatment
This study isn't currently recruiting.
In France
Get research updatesBipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
This study isn't currently recruiting.
In FranceThis study isn't currently recruiting.
In United KingdomThis study isn't currently recruiting.
In ItalyThis study evaluated the safety and effectiveness of risperidone for people with bipolarity.
This study has finished and is no longer accepting participants.
Location not clearly listedThis study evaluated the safety and effectiveness of risperidone for people with bipolarity.
This study has finished and is no longer accepting participants.
Location not clearly listedA Double-Blind, Placebo-Controlled Trial of Asenapine in the Prevention of Recurrence of a Mood Episode After Stabilization of an Acute Manic/Mixed Episode in Subjects With Bipolar 1 Disorder (Phase 3B, Protocol P06384)
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimResearchers compared Asenapine and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I.
This study has finished and is no longer accepting participants.
Location not clearly listedFunctional Correlates of Bipolar Disorders and Effects of the Psychoeducation. Assessment by Functional and Anatomic Neuroimaging.
This study has finished and is no longer accepting participants.
In GrenobleA 6-Week Randomised, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy of Lurasidone Adjunctive Therapy in Improving Cognitive Functioning in Euthymic Bipolar Disorder Pa...
Original registry wording; source language not specified.
Current recruitment status is unconfirmed.
This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.
In United KingdomAdjunct pioglitazone IN THE TREATMENT OF BIPOLAR DISORDER.
Original registry wording; source language not specified.
Current recruitment status is unconfirmed.
This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.
In SpainOptimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder
Original registry wording; source language not specified.
Current recruitment status is unconfirmed.
This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.
In DenmarkRANDOMIZED, CONTROLLED, MULTI-CENTER, INTERNATIONAL CLINICAL STUDY ON THE MOOD-STABILIZING EFFECTS OF MEMANTINE AS AN AUGMENTING AGENT vs. LAMOTRIGINE FOR ONGOING TREATMENT IN BIPOLAR-I DISORDER P...
Original registry wording; source language not specified.
Current recruitment status is unconfirmed.
This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.
In ItalyWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.